Abdullatif Al-Khal
Overview
Explore the profile of Abdullatif Al-Khal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chemaitelly H, Ayoub H, Faust J, Coyle P, Tang P, Hasan M, et al.
BMJ Public Health
. 2025 Feb;
1(1):e000479.
PMID: 40017867
Objective: To assess the evolution of COVID-19 severity and fatality in a unique setting that consistently applied, throughout the pandemic, rigorous and standardised criteria for defining severe COVID-19 outcomes. Methods...
2.
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H, et al.
Nature
. 2025 Feb;
PMID: 39910292
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved over short timescales, leading to the emergence of more transmissible variants such as Alpha and Delta. The arrival of...
3.
Aqel S, Thalappil S, Imameldin A, Mudawi D, Al Maslamani M, Al-Khal A, et al.
Front Allergy
. 2025 Jan;
5():1502285.
PMID: 39845650
Introduction: COVID-19 vaccination has been a key intervention in reducing the severity of symptoms; however, concerns about vaccine safety, particularly regarding allergic reactions, arose early on. Healthcare workers faced the...
4.
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H, et al.
Influenza Other Respir Viruses
. 2024 Sep;
18(10):e13357.
PMID: 39343986
Background: This study provides a head-to-head comparison of the protection provided by the BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection and against severe COVID-19, covering primary series and third dose/booster...
5.
Yousuf A, Stewart D, Kane T, Soltani A, Al-Khal A, Sethi A
Front Med (Lausanne)
. 2024 Sep;
11:1440867.
PMID: 39290389
Introduction: Breaking bad news is a critical yet challenging aspect of healthcare that requires effective communication skills, empathy, and cultural sensitivity. Health professionals in the World Health Organization's (WHO) Eastern...
6.
Ansari A, Ahmad F, Alam M, Raheed T, Zaqout A, Al-Maslamani M, et al.
Rev Med Virol
. 2024 Aug;
34(5):e2578.
PMID: 39192485
A wide variety of inflammatory mediators, mainly cytokines and chemokines, are induced during SARS CoV-2 infection. Among these proinflammatory mediators, chemokines tend to play a pivotal role in virus-mediated immunopathology....
7.
Chemaitelly H, Akhtar N, Al Jerdi S, Kamran S, Joseph S, Morgan D, et al.
Int J Infect Dis
. 2024 May;
145:107095.
PMID: 38777080
Objective: This study investigated the association between Coronavirus Disease 2019 mRNA vaccination and stroke in Qatar. Methods: Between December 1, 2020, and April 11, 2023, a matched case-control study was...
8.
Ibrahim T, Thomas M, Rasheed I, Mobayed H, Abdul Sattar H, Al-Khal A, et al.
Qatar Med J
. 2024 Apr;
2024(2):23.
PMID: 38680397
No abstract available.
9.
Sukik L, Chemaitelly H, Ayoub H, Coyle P, Tang P, Yassine H, et al.
Vaccine
. 2024 Apr;
42(14):3307-3320.
PMID: 38616439
Background: Vaccines were developed and deployed to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to characterize patterns in the protection provided by the BNT162b2 and...
10.
Chemaitelly H, Coyle P, Ben Kacem M, Ayoub H, Tang P, Hasan M, et al.
J Travel Med
. 2024 Apr;
31(4).
PMID: 38591115
No abstract available.